Repligen (RGEN) Cash from Investing Activities Growth (1y) (2011 - 2026)
Powered by 
Analysis
Repligen (RGEN) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -3,832.95% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -975.00% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -148.98% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 81.42% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -1,838.18% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 42.20% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 73.35% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -723.75% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 72.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.35% |
| Mar 31, 2026 | 94.62% |
| Dec 31, 2025 | -222.32% |
| Sep 30, 2025 | -32.84% |
| Jun 30, 2025 | -5.93% |
| Mar 31, 2025 | -786.25% |
| Dec 31, 2024 | 61.88% |
| Sep 30, 2024 | 33.19% |
| Jun 30, 2024 | -111.41% |
| Mar 31, 2024 | 11.35% |
| Dec 31, 2023 | -40.06% |
| Sep 30, 2023 | 84.75% |
| Jun 30, 2023 | 347.27% |
| Mar 31, 2023 | 66.57% |
| Dec 31, 2022 | -94.79% |
| Sep 30, 2022 | 56.67% |
| Jun 30, 2022 | -52.43% |
| Mar 31, 2022 | -213.59% |
| Dec 31, 2021 | 60.66% |
| Sep 30, 2021 | -295.16% |